Group Sequential Clinical Trial Designs for Normally Distributed Outcome Variables

10/09/2017

∙

by   Michael Grayling, et al.

∙

0

∙

share

In a group sequential clinical trial, accumulated data are analysed at numerous time-points in order to allow early decisions about a hypothesis of interest. These designs have historically been recommended for their ethical, administrative and economic benefits. In this work, we discuss a collection of new Stata commands for computing the stopping boundaries and required group size of various classical group sequential designs, assuming a normally distributed outcome variable. Following this, we demonstrate how the performance of several designs can be compared graphically.